305 related articles for article (PubMed ID: 37460928)
41. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
Škapa P; Dundr P
Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients.
Zong H; Zhang J; Xu Z; Pan JN; Wang R; Han J; Jiang M; Ren R; Zang L; Wang H; Cao WM
J Cancer; 2022; 13(4):1119-1129. PubMed ID: 35281878
[No Abstract] [Full Text] [Related]
43. Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers.
Wen H; Xu Q; Sheng X; Li H; Wang X; Wu X
JAMA Netw Open; 2023 Jul; 6(7):e2326437. PubMed ID: 37523182
[TBL] [Abstract][Full Text] [Related]
44. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract][Full Text] [Related]
45. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
[TBL] [Abstract][Full Text] [Related]
46. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
47. Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing.
Lopacinska-Joergensen J; Oliveira DVNP; Poulsen TS; Hoegdall CK; Hoegdall EV
Anticancer Res; 2023 May; 43(5):1891-1900. PubMed ID: 37097678
[TBL] [Abstract][Full Text] [Related]
48. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
Pennington KP; Walsh T; Lee M; Pennil C; Novetsky AP; Agnew KJ; Thornton A; Garcia R; Mutch D; King MC; Goodfellow P; Swisher EM
Cancer; 2013 Jan; 119(2):332-8. PubMed ID: 22811390
[TBL] [Abstract][Full Text] [Related]
49. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
[TBL] [Abstract][Full Text] [Related]
50. The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.
Cheng Z; Mirza H; Ennis DP; Smith P; Morrill Gavarró L; Sokota C; Giannone G; Goranova T; Bradley T; Piskorz A; Lockley M; ; Kaur B; Singh N; Tookman LA; Krell J; McDermott J; Macintyre G; Markowetz F; Brenton JD; McNeish IA
Clin Cancer Res; 2022 Jul; 28(13):2911-2922. PubMed ID: 35398881
[TBL] [Abstract][Full Text] [Related]
51. Endometrial Cancers in
Smith ES; Da Cruz Paula A; Cadoo KA; Abu-Rustum NR; Pei X; Brown DN; Ferrando L; Sebastiao APM; Riaz N; Robson ME; Soslow RA; Reis-Filho JS; Mandelker D; Weigelt B
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914019
[TBL] [Abstract][Full Text] [Related]
52. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
[TBL] [Abstract][Full Text] [Related]
53. Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response.
De Picciotto N; Cacheux W; Roth A; Chappuis PO; Labidi-Galy SI
Crit Rev Oncol Hematol; 2016 May; 101():50-9. PubMed ID: 26964893
[TBL] [Abstract][Full Text] [Related]
54. Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.
Hennessy BT; Timms KM; Carey MS; Gutin A; Meyer LA; Flake DD; Abkevich V; Potter J; Pruss D; Glenn P; Li Y; Li J; Gonzalez-Angulo AM; McCune KS; Markman M; Broaddus RR; Lanchbury JS; Lu KH; Mills GB
J Clin Oncol; 2010 Aug; 28(22):3570-6. PubMed ID: 20606085
[TBL] [Abstract][Full Text] [Related]
55. High-grade serous ovarian carcinoma and detection of inactivated BRCA genes from biopsy material of Slovak patients.
Janíková K; Váňová B; Grendár M; Samec M; Líšková A; Loderer D; Kašubová I; Farkašová A; Scheerova K; Slávik P; Lasabová Z; Danková Z; Plank L
Neoplasma; 2021 Sep; 68(5):1107-1112. PubMed ID: 34263651
[TBL] [Abstract][Full Text] [Related]
56. Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.
Ritterhouse LL; Nowak JA; Strickland KC; Garcia EP; Jia Y; Lindeman NI; Macconaill LE; Konstantinopoulos PA; Matulonis UA; Liu J; Berkowitz RS; Nucci MR; Crum CP; Sholl LM; Howitt BE
Mod Pathol; 2016 Aug; 29(8):893-903. PubMed ID: 27150160
[TBL] [Abstract][Full Text] [Related]
57. Integrated analysis of germline and somatic variants in ovarian cancer.
Kanchi KL; Johnson KJ; Lu C; McLellan MD; Leiserson MD; Wendl MC; Zhang Q; Koboldt DC; Xie M; Kandoth C; McMichael JF; Wyczalkowski MA; Larson DE; Schmidt HK; Miller CA; Fulton RS; Spellman PT; Mardis ER; Druley TE; Graubert TA; Goodfellow PJ; Raphael BJ; Wilson RK; Ding L
Nat Commun; 2014; 5():3156. PubMed ID: 24448499
[TBL] [Abstract][Full Text] [Related]
58. Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.
Bodily WR; Shirts BH; Walsh T; Gulsuner S; King MC; Parker A; Roosan M; Piccolo SR
PLoS One; 2020; 15(9):e0239197. PubMed ID: 32997669
[TBL] [Abstract][Full Text] [Related]
59. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
[TBL] [Abstract][Full Text] [Related]
60. Molecular Genetic Characteristics of
Fierheller CT; Alenezi WM; Serruya C; Revil T; Amuzu S; Bedard K; Subramanian DN; Fewings E; Bruce JP; Prokopec S; Bouchard L; Provencher D; Foulkes WD; El Haffaf Z; Mes-Masson AM; Tischkowitz M; Campbell IG; Pugh TJ; Greenwood CMT; Ragoussis J; Tonin PN
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833203
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
